关注
David Liu
David Liu
The University of Oklahoma
在 alumni.cmu.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Scaling of theory‐of‐mind tasks
HM Wellman, D Liu
Child development 75 (2), 523-541, 2004
28362004
Oncogenic signaling pathways in the cancer genome atlas
F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ...
Cell 173 (2), 321-337. e10, 2018
25122018
Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a …
ED Kwon, CG Drake, HI Scher, K Fizazi, A Bossi, AJM Van den Eertwegh, ...
The lancet oncology 15 (7), 700-712, 2014
15752014
A cancer cell program promotes T cell exclusion and resistance to checkpoint blockade
L Jerby-Arnon, P Shah, MS Cuoco, C Rodman, MJ Su, JC Melms, ...
Cell 175 (4), 984-997. e24, 2018
10542018
Brivanib versus sorafenib as first-line therapy in patients with unresectable, advanced hepatocellular carcinoma: results from the randomized phase III BRISK-FL study
PJ Johnson, S Qin, JW Park, RTP Poon, JL Raoul, PA Philip, CH Hsu, ...
Journal of clinical oncology 31 (28), 3517-3524, 2013
8382013
The long tail of oncogenic drivers in prostate cancer
J Armenia, SAM Wankowicz, D Liu, J Gao, R Kundra, E Reznik, ...
Nature genetics 50 (5), 645-651, 2018
7432018
Steps in Theory‐of‐Mind Development for Children With Deafness or Autism
CC Peterson, HM Wellman, D Liu
Child Development 76 (2), 502-517, 2005
6682005
Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma
D Liu, B Schilling, D Liu, A Sucker, E Livingstone, L Jerby-Arnon, ...
Nature medicine 25 (12), 1916-1927, 2019
6622019
Brivanib in patients with advanced hepatocellular carcinoma who were intolerant to sorafenib or for whom sorafenib failed: results from the randomized phase III BRISK-PS study
JM Llovet, T Decaens, JL Raoul, E Boucher, M Kudo, C Chang, YK Kang, ...
Journal of Clinical Oncology 31 (28), 3509-3516, 2013
6622013
ERKMAPK activity as a determinant of tumor growth and dormancy; regulation by p38SAPK
JA Aguirre-Ghiso, Y Estrada, D Liu, L Ossowski
Cancer research 63 (7), 1684-1695, 2003
6292003
Multi-institutional clinical experience with the Calypso System in localization and continuous, real-time monitoring of the prostate gland during external radiotherapy
P Kupelian, T Willoughby, A Mahadevan, T Djemil, G Weinstein, S Jani, ...
International Journal of Radiation Oncology* Biology* Physics 67 (4), 1088-1098, 2007
5692007
Theory of mind development in Chinese children: A meta-analysis of false-belief understanding across cultures and languages.
D Liu, HM Wellman, T Tardif, MA Sabbagh
Developmental Psychology 44 (2), 523, 2008
5682008
Adopt a moratorium on heritable genome editing
ES Lander, F Baylis, F Zhang, E Charpentier, P Berg, C Bourgain, ...
Nature 567 (7747), 165-168, 2019
5272019
Urokinase Receptor and Fibronectin Regulate the ERKMAPK to p38MAPK Activity Ratios That Determine Carcinoma Cell Proliferation or Dormancy In Vivo
JA Aguirre-Ghiso, D Liu, A Mignatti, K Kovalski, L Ossowski
Molecular biology of the cell 12 (4), 863-879, 2001
5202001
Spread of methicillin-resistant Staphylococcus aureus between the community and the hospitals in Asian countries: an ANSORP study
JH Song, PR Hsueh, DR Chung, KS Ko, CI Kang, KR Peck, JS Yeom, ...
Journal of antimicrobial chemotherapy 66 (5), 1061-1069, 2011
5042011
Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors
D Miao, CA Margolis, NI Vokes, D Liu, A Taylor-Weiner, SM Wankowicz, ...
Nature genetics 50 (9), 1271-1281, 2018
5032018
EGFR is a transducer of the urokinase receptor initiated signal that is required for in vivo growth of a human carcinoma
D Liu, JAA Ghiso, Y Estrada, L Ossowski
Cancer cell 1 (5), 445-457, 2002
5032002
Scaling of theory-of-mind understandings in Chinese children
HM Wellman, F Fang, D Liu, L Zhu, G Liu
Psychological science 17 (12), 1075-1081, 2006
4732006
Glidescope® video-laryngoscopy versus direct laryngoscopy for endotracheal intubation: a systematic review and meta-analysis
DEG Griesdale, D Liu, J McKinney, PT Choi
Canadian journal of anaesthesia 59 (1), 41, 2012
4502012
AUGMENT: a phase III study of lenalidomide plus rituximab versus placebo plus rituximab in relapsed or refractory indolent lymphoma
JP Leonard, M Trneny, K Izutsu, NH Fowler, X Hong, J Zhu, H Zhang, ...
Journal of clinical oncology 37 (14), 1188-1199, 2019
3832019
系统目前无法执行此操作,请稍后再试。
文章 1–20